welcome to dox-al Australia
Dox-al Australia Pty Ltd is a member of the global Dox-al community.
Our company is based on forty years of applied research interfaced to academic institutions all over Europe, the result of which is over 20 original patents benefiting our industry. Our scientific developments are applied by multi-national feed additive manufacturers in many countries and are used under license in the manufacture of their own products or in products they use in production.
Dox-al invented technologies in some cases are preferred or demanded by regulatory bodies as a condition of registration for certain feed additives considered problematic. This includes the internationally patented BMP® or Bi Modal Protection technology used by a plethora of manufacturers of feed additives internationally.
Dox-al are EU GMP, ISO 9001 and FAMI accredited for manufacturing and during 2006, Dox-al Italia SpA received US - FDA accreditation.
Based on five continents, Dox-al develop, manufacture and market a range of high quality feed ingredients, antibiotics and therapeutic drugs. With the introduction of Dox-al's Bio-Tech program, we have become an industry leader in modified and tailored natural yeast based therapies for the stockfeed and animal health industries.
Dox-al aim to improve standards within our industry, create safer working conditions and offer value to the customer while ensuring respect for the environment.
We operate on three basic criteria.
Knowledge, innovation and application.